FDA approves Linzess for IBS, chronic constipation
Linzess sanctioned for constipation that does not respond to conventional treatment.
Drug Approvals
Once-daily pill approved to treat HIV
Stribild, a combination drug that only has to be taken once a day, interferes with enzymes that are needed for HIV to multiply.
Zaltrap approved for advanced colorectal cancer
The FDA has approved ziv-aflibercept (Zaltrap, Sanofi-Aventis) in combination with a FOLFIRI regimen for adults with advanced metastatic colorectal cancer.
Zetonna available soon for allergic rhinitis
Zetonna is a nasal aerosol approved to treat both ocular and nasal symptoms associated with seasonal allergic rhinitis (SAR), and nasal symptoms associated with perennial allergic rhinitis (PAR) in adults and adolescents aged >12 years.
Natazia approved for heavy menstrual bleeding
The FDA has approved the oral contraceptive, Natazia, to treat women with heavy menstrual bleeding that is not caused by a diagnosed condition of the uterus.
FDA approves respiratory distress drug for infants
Surfaxin (lucinactant) is indicated for the prevention of respiratory distress syndrome, a breathing disorder that affects premature infants.
